101 - Update on natural and Prosthetic Vascular Graft Infections

Friday, October 1, 2021

2:45 PM - 4:00 PM EDT

Moderator(s)

Jose M Miro, MD PhD

Dr.
Infectious Diseases Service
Hospital Clinic of Barelona
Barcelona, Catalonia, Spain

Abbvie (Individual(s) Involved: Self): Consultant; Angelini (Individual(s) Involved: Self): Consultant; Contrafect (Individual(s) Involved: Self): Consultant; Cubist (Individual(s) Involved: Self): Consultant; GENENTECH (Individual(s) Involved: Self): Consultant; Gilead (Individual(s) Involved: Self): Consultant
Angela Hewlett, MD, MS

Associate Professor, Division of Infectious Diseases
University of Nebraska Medical Center
Omaha, NE, United States

Mapp Biopharmaceutical, Inc (Individual(s) Involved: Self): Scientific Research Study Investigator

Speaker(s)

Daniel DeSimone, MD

Associate Professor of Medicine
Infectious Diseases
Mayo Clinic
Rochester, MN, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Barbara Hasse, MD

Senior physician
University hospital Zurich
Zuerich, Switzerland

I do not have any relevant financial / non-financial relationships with any proprietary interests.
AP

Andrés Perissinotti, MD PhD

Nuclear Medicine Specialist
Hospital Clínic Barcelona
Barcelona, Spain

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Jose M Miro, MD PhD: Abbvie (Individual(s) Involved: Self): Consultant; Angelini (Individual(s) Involved: Self): Consultant; Contrafect (Individual(s) Involved: Self): Consultant; Cubist (Individual(s) Involved: Self): Consultant; GENENTECH (Individual(s) Involved: Self): Consultant; Gilead (Individual(s) Involved: Self): Consultant

Angela Hewlett, MD, MS: Mapp Biopharmaceutical, Inc (Individual(s) Involved: Self): Scientific Research Study Investigator

Daniel C. DeSimone, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Barbara Hasse, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Andrés Perissinotti, MD PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the clinical picture, diagnostic criteria and prognosis of vascular graft infections
discuss the role of PET/CT on diagnosis and management
implement antibiotic prophylaxis and surgical treatment of vascular graft infections

Presentations:

Antibiotic Prophylaxis and Medical and Surgical Management
Speaker: Daniel C. DeSimone, MD – Mayo Clinic
Clinical picture, diagnostic criteria and prognosis
Speaker: Barbara Hasse, MD – University hospital Zurich
Role of PET/CT and other imaging techniques on diagnosis and management
Speaker: Andrés Perissinotti, MD PhD – Hospital Clínic Barcelona